TD-8236

· Theravance Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TD-8236, covering 2022-03-18 to 2022-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response [Phase 2]